Darker skin types are underrepresented in sunscreen clinical trials: Results of a literature review - 16/09/22
Doi : 10.1016/j.jaad.2021.11.009
Shreya Patel, MD a, ⁎ 
, Jacqueline D. Watchmaker, MD b, c, Jeffrey S. Dover, MD c, d
, Jacqueline D. Watchmaker, MD b, c, Jeffrey S. Dover, MD c, d a Department of Dermatology, Boston University School of Medicine, Boston, Massachusetts
b Southwest Skin Specialists, Scottsdale, Arizona
c SkinCare Physicians, Chestnut Hill, Massachusetts
d Department of Dermatology, Yale University School of Medicine, New Haven, Connecticut
∗Reprint requests: Shreya Patel, MD, Boston University School of Medicine, 609 Albany Street, Boston, MA 02118Boston University School of Medicine609 Albany StreetBostonMA02118
Key words : clinical trials, photoprotection, skin of color, skin type, sunscreen
| Funding sources: This project was accepted for a New England Dermatology Society Preceptorship Grant in 2021, though no funds were used from the grant for the completion of this project. |
|
| IRB approval status: Not applicable. |
© 2021
American Academy of Dermatology, Inc.. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 87 - N° 4
P. 862-864 - octobre 2022 Retour au numéro
Article précédent
- Follicular eczema and accentuation: A survey of published data
- Mark Weingarten, Nanette Silverberg
- The impact of demographic and socioeconomic status on patient perception of barriers to outpatient dermatologic care
- Mallory L. Zaino, Caitlin G. Purvis, Jeremy K. Bray, Matthew L. Hrin, Christine S. Ahn, Steven R. Feldman
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?